Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/short-review-management-of-immune-thrombocytopenia-in-adults-pn0SjhzKC7
References (34)
-
I. Quiquandon, P. Fenaux, M. Caulier, D. Pagniez, J. Huart, F. Bauters (1990)
Re‐evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 casesBritish Journal of Haematology, 74
-
K. Kojouri, S. Vesely, Deirdra Terrell, J. George (2004)
Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications.Blood, 104 9
-
M. Mazzucconi, P. Fazi, S. Bernasconi, G. Rossi, G. Leone, L. Gugliotta, N. Vianelli, G. Avvisati, F. Rodeghiero, A. Amendola, C. Baronci, C. Carbone, S. Quattrin, G. Fioritoni, Giulio D'alfonso, F. Mandelli (2007)
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience.Blood, 109 4
-
F. Maloisel, E. Andrès, J. Zimmer, E. Noel, A. Zamfir, A. Koumarianou, P. Dufour (2004)
Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results.The American journal of medicine, 116 9
-
F. Rodeghiero, M. Ruggeri (2009)
Response:Immune thrombocytopenic purpura: terminology and definitionsBlood, 114
-
Jp Butler, Sts Durrant, T. Frost, R. Hospital, Queensland Australia (2003)
Successful remission of chronic, refractory autoimmune thrombocytopenic purpura following non-myeloablative allogeneic stem cell transplantationBone Marrow Transplantation, 31
-
F. Willis, J. Marsh, D. Bevan, S. Killick, G. Lucas, R. Griffiths, W. Ouwehand, G. Hale, H. Waldmann, E. Gordon-Smith (2001)
The effect of treatment with Campath‐1H in patients with autoimmune cytopeniasBritish Journal of Haematology, 114
-
J. Friedberg, J. Sharman, Julia Schaefer-Cutillo, P. Johnston, S. Vos, A. LaCasce, J. Leonard, L. Cripe, R. Sinha, S. Gregory, J. Sweetenham, J. Vose, A. Lowe, R. Levy, M. Shipp (2008)
Fostamatinib Disodium (FosD), An Oral Inhibitor of Syk, Is Well-Tolerated and Has Significant Clinical Activity in Diffuse Large B Cell Lymphoma (DLBCL) and Chronic Lymphocytic Leukemia (SLL/CLL)Blood, 112
-
J. Bussel, D. Provan, T. Shamsi, G. Cheng, B. Psaila, L. Kovaleva, A. Salama, J. Jenkins, D. Roychowdhury, B. Mayer, N. Stone, M. Arning (2009)
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trialThe Lancet, 373
-
R. Anthony, F. Nimmerjahn, D. Ashline, V. Reinhold, J. Paulson, J. Ravetch (2008)
Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG FcScience, 320
-
D. Arnold, A. Bernotas, I. Nazi, R. Stasi, M. Kuwana, J. Kelton, M. Crowther (2008)
The Efficacy of H. pylori Eradication Therapy in H. pylori-Infected and Uninfected Patients with Immune Thrombocytopenic Purpura: A Systematic Review.Blood, 112
-
Alexander Reiner, T. Gernsheimer, S. Slichter (1995)
Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura.Blood, 85 2
-
F. Zaja, M. Baccarani, P. Mazza, N. Vianelli, M. Bocchia, L. Gugliotta, M. Defina, A. Tieghi, S. Amadori, Selenia Campagna, F. Ferrara, M. Simone, A. Zaccaria, A. Molinari, E. Angelucci, E. Usala, S. Cantoni, Antonella Fornaro, G. Visani, R. Rizzi, V. Stefano, Francesco Casulli, M. Battista, M. Isola, F. Soldano, M. Regazzi, E. Gamba, R. Fanin (2008)
A Prospective Randomized Study Comparing Rituximab and Dexamethasone Vs Dexamethasone Alone in ITP: Results of Final Analysis and Long Term Follow upBlood, 112
-
Suley Vancine-Califani, E. Paula, M. Ozelo, F. Orsi, D. Fabri, J. Annichino-Bizzacchi (2008)
Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpuraPlatelets, 19
-
D. Provan, R. Stasi, A. Newland, V. Blanchette, P. Bolton-Maggs, J. Bussel, B. Chong, D. Cines, T. Gernsheimer, B. Godeau, J. Grainger, I. Greer, B. Hunt, P. Imbach, G. Lyons, R. Mcmillan, F. Rodeghiero, M. Sanz, M. Tarantino, S. Watson, Joan Young, D. Kuter (2010)
International consensus report on the investigation and management of primary immune thrombocytopenia.Blood, 115 2
-
Sung-Won Kim, T. Fukuda, S. Hagiwara, T. Komatsu, Tetsuya Goto, Y. Ueda, Toshiro Ito, M. Hino, K. Sunami, R. Tanosaki, S. Mori, M. Kami, K. Tajima, Y. Takaue (2008)
Randomized Phase II Trial Comparing Cyclosporine (CSP) and Tacrolimus (TAC) for Methotrexate (MTX)-Free Graft-Versus-Host Disease (GVHD) Prophylaxis after Allogeneic Transplantation from a Matched Related Donor (MRD) with a Reduced-Intensity Regimen Containing Cladribine and BusulfanBlood, 112
-
D. Arnold, F. Dentali, M. Crowther, R. Meyer, R. Cook, C. Sigouin, G. Fraser, W. Lim, J. Kelton (2007)
Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic PurpuraAnnals of Internal Medicine, 146
-
R. Huhn, P. Fogarty, R. Nakamura, E. Read, S. Leitman, M. Rick, Janice Kimball, A. Greene, K. Hansmann, A. Gratwohl, N. Young, A. Barrett, C. Dunbar (2003)
High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia.Blood, 101 1
-
F Rodeghiero, M Ruggeri (2009)
Immune thrombocytopenic purpura: terminology and definitions responseBlood, 114
-
Donna Boruchov, S. Gururangan, M. Driscoll, J. Bussel (2007)
Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP).Blood, 110 10
-
D. Provan, Ashley Moss, A. Newland, J. Bussel (2006)
Efficacy of mycophenolate mofetil as single‐agent therapy for refractory immune thrombocytopenic purpuraAmerican Journal of Hematology, 81
-
R. Emmons, D. Reid, R. Cohen, G. Meng, N. Young, C. Dunbar, N. Shulman (1996)
Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction.Blood, 87 10
-
D. Kuter, J. Bussel, R. Lyons, V. Pullarkat, T. Gernsheimer, F. Senecal, L. Aledort, J. George, C. Kessler, M. Sanz, H. Liebman, F. Slovick, J. Wolf, E. Bourgeois, T. Guthrie, A. Newland, J. Wasser, S. Hamburg, C. Grande, F. Lefrère, A. Lichtin, M. Tarantino, H. Terebelo, J. Viallard, Francis Cuevas, R. Go, D. Henry, R. Redner, L. Rice, M. Schipperus, D. Guo, J. Nichol (2008)
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialThe Lancet, 371
-
Joseph Spahr, G. Rodgers (2008)
Treatment of immune‐mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: A retrospective review of 40 patientsAmerican Journal of Hematology, 83
-
R. Mcmillan (2001)
Long-term outcomes after treatment for refractory immune thrombocytopenic purpura.The New England journal of medicine, 344 18
-
A. Podolanczuk, A. Lazarus, A. Crow, E. Grossbard, J. Bussel (2009)
Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk.Blood, 113 14
-
R. Stasi, Ameet Sarpatwari, J. Segal, J. Osborn, M. Evangelista, N. Cooper, D. Provan, A. Newland, S. Amadori, J. Bussel (2009)
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review.Blood, 113 6
-
M. Figueroa, J. Gehlsen, D. Hammond, S. Ondreyco, L. Piro, Talisman Pomeroy, Frederick Williams, R. Mcmillan (1993)
Combination chemotherapy in refractory immune thrombocytopenic purpura.The New England journal of medicine, 328 17
-
J. Andersen (1994)
Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy.The New England journal of medicine, 330 22
-
A. Gasbarrini, F. Franceschi, R. Tartaglione, R. Landolfi, P. Pola, G. Gasbarrini (1998)
Regression of autoimmune thrombocytopenia after eradication of Helicobacter pyloriThe Lancet, 352
-
G. Emilia, M. Morselli, M. Luppi, G. Longo, R. Marasca, G. Gandini, L. Ferrara, N. D'Apollo, L. Potenza, M. Bertesi, G. Torelli (2002)
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura.Blood, 99 4
-
K. Kaushansky (1995)
Thrombopoietin: the primary regulator of platelet production.Blood, 86 2
-
J. Carr, M. Kruskall, J. Kaye, S. Robinson (1986)
Efficacy of platelet transfusions in immune thrombocytopenia.The American journal of medicine, 80 6
-
J. George, S. Woolf, G. Raskob, J. Wasser, L. Aledort, P. Ballem, V. Blanchette, J. Bussel, D. Cines, J. Kelton, A. Lichtin, R. Mcmillan, J. Okerbloom, D. Regan, I. Warrier (1996)
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.Blood, 88 1
- Publisher
- Springer Journals
- Copyright
- Copyright © 2010 by Springer
- Subject
- Medicine & Public Health; Medicine/Public Health, general ; Oncology
- ISSN
- 1865-5041
- eISSN
- 1865-5076
- DOI
- 10.1007/s12254-010-0189-4
- Publisher site
- See Article on Publisher Site
Abstract
In recent years clinical management of Immune Thrombocytopenia (ITP) has clearly changed due to the emergence of new therapeutics such as Thrombopoietin Receptor Agonists or Rituximab. These agents have been tested in phase III randomized controlled trials and thereby initiated an impulse for the whole field of ITP. Moreover, in 2009 various publications systematically reviewed current practice, presented efforts of standardization as well as new guidelines for diagnosis and treatment of ITP. This short review is intended to summarize these new developments and to propose an up-dated treatment algorithm.
Journal
memo - Magazine of European Medical Oncology – Springer Journals
Published: Jun 18, 2010